News Sentiment

KTTA sentiment intelligence

Pasithea Therapeutics Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.45 Week of 17 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

87/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-8.6% over one week, -10.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Pasithea Therapeutics (KTTA) Proxy filing Summary

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 87/100 classification
One-week reaction -8.6% Price reacting lower
Trend fit Trend inactive -10.0% over four weeks
Fair value -87.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 34
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 9
Stock Titan 7
GlobeNewswire 4
MT Newswires 3
simplywall.st 3
Quartr 2
Sahm 2

Event Lens

What the news is about

Classified themes
Market update 40
Earnings 13
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
Zacks Investment Research Direct company coverage

Pasithea Therapeutics (KTTA)

Tone
Neutral 50/100
Event
Market update
Published
17 Sep 2021 11:59
Source
Zacks Investment Research